Dockside LLC Buys New Holdings in Sabra Healthcare REIT, Inc. $SBRA

Dockside LLC bought a new stake in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor bought 102,438 shares of the real estate investment trust’s stock, valued at approximately $1,940,000.

A number of other large investors have also recently bought and sold shares of the company. Principal Financial Group Inc. boosted its position in Sabra Healthcare REIT by 21.6% in the 4th quarter. Principal Financial Group Inc. now owns 24,953,351 shares of the real estate investment trust’s stock worth $472,617,000 after purchasing an additional 4,431,897 shares in the last quarter. Lasalle Investment Management Securities LLC purchased a new stake in Sabra Healthcare REIT in the 4th quarter worth approximately $66,938,000. Norges Bank purchased a new stake in Sabra Healthcare REIT in the 4th quarter worth approximately $57,945,000. Sumitomo Mitsui Trust Group Inc. boosted its position in Sabra Healthcare REIT by 1,019.8% in the 4th quarter. Sumitomo Mitsui Trust Group Inc. now owns 3,005,374 shares of the real estate investment trust’s stock worth $56,922,000 after purchasing an additional 2,736,993 shares in the last quarter. Finally, Balyasny Asset Management L.P. purchased a new stake in Sabra Healthcare REIT in the 2nd quarter worth approximately $49,955,000. Hedge funds and other institutional investors own 99.40% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have commented on SBRA shares. Weiss Ratings lowered Sabra Healthcare REIT from a “buy (b+)” rating to a “buy (b)” rating in a research report on Thursday, June 4th. Wells Fargo & Company upped their price objective on Sabra Healthcare REIT from $22.00 to $23.00 and gave the stock an “overweight” rating in a research report on Monday, June 1st. Truist Financial upped their price objective on Sabra Healthcare REIT from $21.00 to $22.00 and gave the stock a “hold” rating in a research report on Friday, March 13th. Citizens Jmp upped their price objective on Sabra Healthcare REIT from $22.00 to $23.00 and gave the stock a “market outperform” rating in a research report on Wednesday, February 18th. Finally, Citigroup upped their price objective on Sabra Healthcare REIT from $21.00 to $24.00 and gave the stock a “buy” rating in a research report on Wednesday, February 18th. Five research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the stock. Based on data from MarketBeat.com, Sabra Healthcare REIT has a consensus rating of “Moderate Buy” and a consensus price target of $22.40.

Sabra Healthcare REIT Trading Up 1.3%

Shares of NASDAQ:SBRA opened at $18.73 on Friday. Sabra Healthcare REIT, Inc. has a 1 year low of $17.17 and a 1 year high of $21.28. The firm has a market capitalization of $4.72 billion, a price-to-earnings ratio of 29.73, a price-to-earnings-growth ratio of 1.39 and a beta of 0.64. The company has a debt-to-equity ratio of 0.96, a current ratio of 4.72 and a quick ratio of 4.72. The business’s 50 day moving average price is $20.06 and its 200-day moving average price is $19.68.

Sabra Healthcare REIT (NASDAQ:SBRA) last announced its earnings results on Wednesday, April 29th. The real estate investment trust reported $0.16 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.16. Sabra Healthcare REIT had a return on equity of 5.60% and a net margin of 19.22%.The firm had revenue of $211.74 million for the quarter, compared to analyst estimates of $209.20 million. During the same quarter last year, the firm posted $0.37 EPS. The business’s revenue was up 20.9% on a year-over-year basis. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. On average, equities research analysts forecast that Sabra Healthcare REIT, Inc. will post 1.51 earnings per share for the current fiscal year.

Sabra Healthcare REIT Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, May 29th. Stockholders of record on Friday, May 15th were given a dividend of $0.30 per share. The ex-dividend date was Friday, May 15th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 6.4%. Sabra Healthcare REIT’s dividend payout ratio (DPR) is 190.48%.

Sabra Healthcare REIT Company Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.